ABHD5 and colorectal neoplasm: Using a combination of genetically engineered mouse models and molecular cellular approaches, these authors discovered that intestine-specific ablation of ABHD5 dramatically promotes metastatic progression of colorectal tumor, by downregulation of AMPK/p53 signaling and thereby promoting the epithelial to mesenchymal transition (EMT)22.